Lack of effect of guideline changes on hypertension control for patients with diabetes in the U.S., 1995-2005

Diabetes Care

Volumn 30, Issue 1, 2007, Pages 49-52

  Wang, Y Richard ^a,b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CONTROL; HEALTH SURVEY; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRACTICE GUIDELINE; PUBLICATION; REVIEW; UNITED STATES;

BLOOD PRESSURE; DIABETIC ANGIOPATHIES; HUMANS; HYPERTENSION; PRACTICE GUIDELINES; REFERENCE VALUES; REGRESSION ANALYSIS; UNITED STATES;

EID: 33845986341     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1573     Document Type: Review

References (22)

1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:1560-2572, 2003
3. IMS Health. NDTI Diagnosis Reference File, 1995 to 2005. Plymouth Meeting, PA: IMS Health 1995 to 2005
4. Munnangi S, Sonnenberg A: Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States. Arch Intern Med 157:1489-1494, 1997
5. Stafford RS, Blumenthal D, Pasternak RC: Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol 29:139 -146, 1997
6. Stafford RS, Radley DC: The underutilization of cardiac medications of proven benefit, 1990-2002. J Am Coll Cardiol 41:56-61, 2003
7. Wang YR, Alexander GC, Meltzer DO: Lack of effect of guideline changes on LDL cholesterol reporting and control for diabetes visits in the U.S., 1995-2004. Diabetes Care 28:2942-2944, 2005
8. Wang YR, Alexander GC, Meltzer DO: Screening and treatment of hypercholesterolemia for prevention of coronary heart disease. Managed Care Interface 19:25-29, 2006
9. Practice Management Information Corporation. ICD-9-CM: International classification of diseases, Ninth revision, Clinical Modifications, 5th ed., 1999, Hospital Edition, Volume 1. Los Angeles, California, 1998
10. National Committee for Quality Assurance: New collaborative diabetes initiative could change the face of diabetes care in America [article online], 14 August 1997. Available from http://www.ncqa.org/communications/news/diabrel. htm. Accessed 2 May 2004
11. Beaton AJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM: Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 27:694-698, 2004
12. Andrade SE, Gurwitz JH, Field TS, Kelleher M, Majumdar SR, Reed G, Black R: Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care 10:481-186, 2004
13. Bergenstal RM, Nag SS, Reusch JE, Sajjan SG, Alexander CM: Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. Endocr Pract 11:172-179, 2005
14. Greenberg JD, Tiwari A, Rajan M, Miller D, Natarajan S, Pogach L: Determinants of sustained uncontrolled blood pressure in a national cohort of persons with diabetes. Am J Hypertens 19:161-9, 2006
15. Hill MN, Levine DM, Whelton PK: Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Am J Public Health 78:1190-1194, 1988
16. Siegel D, Lopez J: Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 278:1745-1748, 1997
17. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayer B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363-2369, 2003
18. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayer B, Thamm M: Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43:10 -17, 2004
19. Hajjar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290:199-206, 2003
20. Bonow RO, Smaha LA, Smith SC, Mensah GA, Lenfant C: World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106:1602-1605, 2002
21. Menard J, Chatellier G: Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 9 (Suppl. 2):S19 -S23, 1995
22. Blonde L: Current challenges in diabetes management. Clin Cornerstone 7 (Suppl. 3):S6 -S17, 2005